Biomarkers and Biologics: Advancing Selection and Monitoring of Targeted Therapies for Severe Asthma Evaluation (ID: i842a-1) Survey

1.What is your degree?(Required.)

MD/DO

PA

NP

RN

Other (please specify)

3.How many years have you been in practice?(Required.)

>21

11-20

1-10

<1

4.How many patients with severe asthma do you manage per week?  (Required.)

1 to 10

11 to 25

26 to 50

I am not directly involved in patient care

5.Please select the option that best describes your practice setting.(Required.)

6.After participating in this activity, how confident are you in the management of patients with severe asthma in your practice?(Required.)

7.How committed are you to making changes in your practice based on your participation in this activity? (Required.)

If not committed or do not plan to make changes, please indicate reason

8.Which of the following best describes the impact of this activity on your performance? (Required.)

I gained new strategies/skills/information I can apply to my area of practice

I need more information before I can change my practice

My practice is already consistent with the information presented

This activity will not change my practice

9.Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.(Required.)

Improved knowledge of the role of FeNO, particularly in the evaluation of patient phenotype

Discuss predictors of biologic response based on biomarker tests

Improved knowledge of individual patient characteristics that lend to selection of one biologic over another

Select appropriate biologic therapy for standardized patients with severe asthma

Improved knowledge of guidelines for biologic monitoring, switching, and discontinuation strategies, as well as recent evidence on patient outcomes following biologic therapy change

Improved competence to monitor and evaluate standardized patient for biologic switching

10.What barriers do you see to making changes in your practice? Please select all that apply(Required.)

Lack of knowledge regarding evidence-based strategies

Lack of convincing evidence to warrant change

Lack of time/resources to consider change

Insurance, reimbursement or legal issues

Conflicting guidelines or evidence

Patient compliance and/or patient resource barriers

Other (please explain)

14.If you indicated that you perceived commercial bias or influence, please describe:

15.As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?

16.Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities for severe asthma: